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Perinatal asphyxia (PA) is an obstetric complication that strongly affects the CNS.
The endocannabinoid system (ECS) is a lipid transmitter system involved in several
physiological processes including synaptic plasticity, neurogenesis, memory, and
mood. Endocannabinoids, and other acylethanolamides (AEs) without endocannabinoid
activity, have recently received growing attention due to their potential neuroprotective
functions in neurological disorders, including cerebral ischemia. In the present study, we
aimed to analyze the changes produced by PA in the major metabolic enzymes and
receptors of the ECS/AEs in the hippocampus using a rodent model of PA. To induce
PA, we removed uterine horns from ready-to-deliver rats and immersed them into a
water bath during 19 min. Animals delivered spontaneously or by cesarean section
were employed as controls. At 1 month of age, cognitive functions were assessed
and immunohistochemical procedures were carried out to determine the expression
of NeuN and glial fibrillary acidic protein, enzymes responsible for synthesis (DAGLα
and NAPE-PLD) and degradation (FAAH) of ECS/AEs and their receptors (CB1 and
PPARα) in the hippocampus. Postweaned asphyctic rats showed impaired recognition
and spatial reference memory that were accompanied by hippocampal astrogliosis and
changes in the expression of enzymes and receptors. The most remarkable findings
in asphyctic rats were a decrease in the expression of NAPE-PLD and PPARα in
both hippocampal areas CA1 and CA3. In addition, postweaned cesarean delivery rats
showed an increase in the immunolabeling for FAAH in the hippocampal CA3 area.
Since, NAPE-PLD and PPARα are proteins that participate in the biochemical process
of AEs, specially the neuroprotective oleoylethanolamide, these results suggest that PA
dysregulates this system. These data encourage conducting future studies using AEs
as potential neuroprotective compounds in animal models of PA.
Keywords: perinatal asphyxia, hippocampus, memory, DAGLα, NAPE-PLD, CB1, PPARα, FAAH
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INTRODUCTION
Perinatal asphyxia (PA) is an obstetric complication that can be
triggered by diﬀerent events, such as fetus lungs malfunction
and alterations in the gas exchange in the placenta, leading to
lack of oxygen (hypoxia) or a reduced blood ﬂow (ischemia)
to diﬀerent body organs during the perinatal period (Carrera,
2006). PA aﬀects every organ in the body and it is predominantly
deleterious for the central nervous system (CNS; Kumar et al.,
2007). The CNS is highly susceptible to the oxidative damage
caused by PA due to its elevated concentrations of unsaturated
fatty acids, high oxygen consumption, and little concentration
of antioxidants (Halliwell, 1992). PA is associated with high
morbimortality in term and pre-term neonates (Lawn et al.,
2005). Following PA, 25% of those newborns who survive
develop neurological disorders, such as cerebral palsy and
several neurodevelopmental and learning disabilities (Amiel-
Tison and Ellison, 1986; Mañeru et al., 2001; van Handel et al.,
2007).
Several murine and rodent models are employed to study
PA in experimental conditions. Two of the most renowned are
the ones developed by Bjelke et al. (1991) and Vannucci et al.
(1999). The former is induced in pup rats of 7 days of age by
ligation of the right common carotid artery followed by exposure
to an oxygen-deprived environment (Vannucci et al., 1999),
while the one developed by Bjelke et al. (1991) is carried out
by immersing uterus horns, containing the fetuses, into a water
bath set at 37◦C for diﬀerent time periods. Uterus horns are
obtained from pregnant rats that are ready to deliver (Bjelke et al.,
1991; Capani et al., 2001). Bjelke’s model is a well-established
PA model that has been extensively employed by our and other
groups (Chen et al., 1995; Capani et al., 1997, 2001, 2003, 2009;
Brake et al., 2000; Boksa and El-Khodor, 2003; Weitzdoerfer
et al., 2004; Cebral et al., 2006; Wakuda et al., 2008; Morales
et al., 2010; Saraceno et al., 2010, 2012; Strackx et al., 2010).
Using this model, it has been observed that during this stage
of development, PA may cause damage in several regions of
the CNS, such as hippocampus, cerebellum, striatum, cerebral
cortex, and substantia nigra (Bjelke et al., 1991; Capani et al.,
2009; Campanille et al., 2015). The model has many advantages
over others, such as: (a) the asphyxia is induced during delivery,
reproducing clinical situations with more accuracy. For instance,
when the circulation of the umbilical cord is altered (Capani
et al., 2009); (b) it aﬀects the whole body, mimicking global
asphyxia which is the most frequent type of PA (Lubec et al., 1997;
Loidl et al., 2000; Strackx et al., 2010); (c) it does not require
surgical procedures which could add confounding eﬀects; (d)
both cerebral hemispheres and deep brain structures are aﬀected
by hypoxia-ischemia.
Our group has previously found that the induction of PA
using the Bjelke’s model is associated to cellular and molecular
changes in the hippocampus, such as focal swelling, astrogliosis,
decreased phosphorylation of high and medium molecular
weight neuroﬁlaments, and synaptic alterations (Saraceno et al.,
2010, 2012). At a behavioral level, we have also observed
spatial reference and working memory impairments in adult and
middle-aged asphyctic rats (Galeano et al., 2011, 2015).
The endocannabinoid system (ECS) is a lipid signaling system
which consists of cannabinoid receptors, endocannabinoids
and enzymes required to synthesize, transport and inactivate
these endogenous ligands (Ueda et al., 2013). The ECS was
originally identiﬁed in the CNS and it has been reported
that it regulates several neurophysiological processes (e.g.,
embryonic cell fate in the developing brain, modulation of
neural development, neurogenesis, and synaptic plasticity)
primarily through the activation of the cannabinoid receptor
type 1 (CB1; Alonso-Alconada et al., 2011; Serrano et al., 2012;
Ueda et al., 2013; Blanco-Calvo et al., 2014). Endocannabinoids
are produced on demand from membrane phospholipids and
degraded by intracellular enzymes. These bioactive lipids are
comprised of two classes of fatty acid derivatives structurally
distinct, acylethanolamides (AEs) and monoacylglycerols
(MAGs). In fact, the best characterized endocannabinoids
are arachidonoylethanolamide (AEA or anandamide) and
2-arachidonoyglycerol (2-AG), both derived from arachidonic
acid (Hansen and Diep, 2009; Serrano et al., 2012; Ueda et al.,
2013). AEA and the rest of AEs are biosynthesized from
glycerophospholipids through two steps. First, the generation
of the precursor N-acyl-phosphatidylethanolamine (NAPE) by
N-acyl transferase; and then, the release of the AE from NAPE
by the NAPE−hydrolyzing phospholipase D (NAPE−PLD).
After completing its physiological activity, AEs are reuptaken
and degraded primarily through the fatty acid amide hydrolase
(FAAH; Okamoto et al., 2009; Ueda et al., 2013; Pasquarelli et al.,
2015). Regarding 2-AG, this MAG shares structural similarities
with AEs but it is synthesized through a pathway involving
diﬀerent enzymes of synthesis and degradation. Thus, the main
synthetic enzyme is the diacylglycerol lipase (DAGL), which
produces 2-AG from arachidonic acid-containing diacylglycerol.
2-AG is later degraded primarily through the MAG lipase
(MAGL) into glycerol and arachidonic acid (Ueda et al., 2013;
Pasquarelli et al., 2015).
Other AEs such as palmitoylethanolamide (PEA) and
oleoylethanolamide (OEA) share with AEA the same
biosynthetic and degradative pathways, but they do not
possess cannabinoid activity because they do not bind to
cannabinoid receptors (Fu et al., 2003). However, PEA and OEA
showed neuromodulatory properties as endogenous agonists
of peroxisome proliferator-activated receptor alpha (PPARα).
PPAR-α is a ligand-activated transcription factor, and it is part
of the nuclear receptor superfamily. This receptor is expressed in
microvascular, neuronal, and glial tissues and plays an important
neuroprotective function in several diseases (Bordet et al., 2006;
Bhateja et al., 2012; Moran et al., 2014).
Although the ECS has demonstrated to exert neuroprotective
eﬀects in models of neonatal and adult cerebral ischemia (Degn
et al., 2007; Alonso-Alconada et al., 2011; Fernández-López
et al., 2013; Esposito et al., 2014; England et al., 2015), these
eﬀects have never been tested in the model of PA developed by
Bjelke et al. (1991). Moreover, there is no available information
about the impact of PA on the expression and activity of the
ECS/AEs system in the brain. In fact, OEA and PEA have shown
neuroprotective eﬀects in adult cerebral ischemia (Ahmad et al.,
2012; Zhou et al., 2012; Yang et al., 2015), but they have never
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been tested in any of the neonatal hypoxia-ischemia models
developed so far. Therefore, the main objective of this work
was to analyze how the ECS/AEs signaling system is aﬀected
in the Bjelke’s rodent model of PA (Bjelke et al., 1991). To this
purpose, we studied the expression of DAGLα, NAPE-PLD, CB1,
PPARα, and FAAH in control (CTL), cesarean delivery (C+) and
asphyctic (PA) 30-days-old rats. Because the dorsal hippocampus
is one of the most vulnerable brain regions to hypoxic-ischemic
injury, we focused our study in this area. In addition, we also
studied the potential deleterious eﬀect of PA on neuron and glial
cells, and cognition.
MATERIALS AND METHODS
Ethics Statement
Experimental procedures that required the use of animals
were approved by: (1) the Institutional Animal Care and Use
Committee of the School of Medicine at the University of Buenos
Aires, (2) the Committee on Ethics of the Hospital R. U. of
Malaga. In addition, the study was carried out following the
European Directive 2010/63/EU on the protection of animals
used for scientiﬁc purposes and Spanish regulations (RD 53/2013
and 178/2004). Every eﬀort was made in order to reduce the
number of animal employed and to minimize animal discomfort.
Animals
Fifteen pregnant Sprague-Dawley rats were purchased from the
School of Veterinary Sciences at the University of Buenos Aires.
Seven days prior to delivery, pregnant rats were transported to
our local vivarium and housed in individual cages in a controlled
temperature (21 ± 2◦C) and humidity (65 ± 5%) environment.
A light/dark cycle of 12:12 h was employed with the light period
beginning at 7 a.m. Food (Purina chow) and tap water were
provided ad libitum. Seven pregnant rats were used as surrogate
mothers while a group of eight pregnant rats was assigned to PA
procedures. After weaning, the oﬀspring was housed in groups
of 3–4 animals of the same experimental condition. Diﬀerent
cohorts of animals were employed for behavioral assessment and
immunohistochemical procedures.
Cesarean Section and Perinatal Asphyxia
Procedures
We employed the PA model developed by Bjelke et al. (1991),
with minor modiﬁcations, as we previously described in Galeano
et al. (2015). Ready-to-deliver pregnant rats (n = 8) “were left to
deliver no more than two pups and were immediately euthanized
by decapitation. Next, the uterus horns were rapidly isolated
through an abdominal incision and one horn was opened, pups
were removed, the amniotic ﬂuid was cleaned, and the umbilical
cord was ligated (cesarean section or C-section procedure).
Concurrently, the remaining horn was placed in a water bath at
37◦C for 19 min (moderate to severe PA). Afterward, the same
procedures performed for the C-section were followed, but before
ligation of the umbilical cord took place, pups were stimulated
to breathe by performing tactile intermittent stimulation with
pieces of medical wipes for a few minutes until regular breathing
was established. This was unnecessary for pups born by C-section
since they started breathing spontaneously.” Male pups that were
born by C-section procedures (cesarean section group, C+) or
by C-section procedures followed by asphyxia (PA) were left
to recover under a heating lamp for ≈1 h. Female pups born
by C-section or by C-section plus asphyxia were immediately
euthanized by decapitation and only male pups were retained for
all subsequent procedures and studies. “When the physiological
conditions of the asphyxiated pups improved, C+ and PA pups
were marked for identiﬁcation and given to surrogate mothers
which had delivered normally within the last 24 h.” Pups born
by vaginal delivery from surrogate mothers were used as controls
(control group, CTL). “A ≈95% of survival rate was observed
in those pups that were born by C-section.” The survival rate
dropped to≈65% in the PA group. “In every case, we maintained
litters of 10 pups with each mother.” All groups were equivalently
represented in each litter.
Behavioral Assessment
Ten rats from each group were submitted to a behavioral test
battery at 30 days of age. Three days before the ﬁrst behavioral
test took place, rats were handled 5 min per day and weighed the
last day. Behavioral tests were performed between 8:00 a.m. and
5:00 p.m. White noise was provided throughout testing. Training
sessions were ﬁlmed using a digital camcorder (JVC Everio GZ-
HD620) and later analyzed with a computerized video-tracking
system (Ethovision XT, version 9, Noldus, Wageningen, The
Netherlands) or with the ethological software JWatcher V1.0.
Novel Object Recognition Test
The Novel Object Recognition Test (NORT) is a behavioral test
that assesses recognition memory (Ennaceur and Delacour, 1988;
Ennaceur, 2010). The apparatus used was an open squared arena
(60 cm × 60 cm × 40 cm) made of black melamine. Illumination
was provided uniformly with a light intensity measured in the
center of the arena of ≈70 lux. To habituate animals to the new
environment, each rat was allowed to freely explore the apparatus
during 10 min 1 day before the NORT was performed. The next
day, NORT was carried out as described in Galeano et al. (2015):
“rats were presented with two identical objects and allowed to
explore them for 5 min (sample trial). Animals were returned to
their cages during the inter-trial interval.” Four hours later, “one
of the two familiar objects was replaced with a novel object and
the rats were again allowed to explore them for 3 min (choice
trial). Sets composed of three copies of the same object were used
to prevent odor cues and all combinations and location of objects
were used to prevent bias due to preference for a particular object
or location. Exploration time was computed when the snout
pointed to the object at a distance ≤2 cm. Discrimination index
(d1) and discrimination ratio (d2) scores were calculated using
the following formulas: d1 = tn – tf, and d2 = (tn – tf)/(tn + tf),
where tn= the amount of time rats explored the novel object and
tf = the amount of time rats explored the familiar object.” It is
important to note that in the present study the inter-trial interval
was longer (4 h) than the one used (1 h) in the previous study by
Galeano et al. (2015).
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Morris Water Maze Test
The apparatus was the same used in previous studies (Galeano
et al., 2014, 2015) consisting “of a circular black galvanized
steel tank (180 cm in diameter and 60 cm deep). The tank was
ﬁlled to a depth of 36–40 cm with water at 22 ± 1◦C. The
maze was divided into four imaginary quadrants (A, B, C, and
D) and a circular platform, made of transparent acrylic, was
placed 2 cm above (visible escape platform) or beneath the water
surface (hidden escape platform), in the center of one of the
quadrants (35 cm from the edge of the tank). To enhance the
visibility of the platform during the cued learning training, a
“ﬂag” was attached to the platform. Four starting positions were
established according to the four quadrants (a, b, c, and d).
To provide external reference points, multiple extra-maze visual
cues of diﬀerent shapes and sizes were hung on the wall of the
experimental room. Indirect illumination was provided by four
spiral compact ﬂuorescent lamps in each corner facing the walls.”
Variables registered were: latency to ﬁnd the escape platform and
swimming speed. During the probe trial, the percentage of time
spent in each quadrant and the number of crossings over the
previous platform location were also registered.
Cued learning
The cued learning was conducted exactly as previously described
by Galeano et al. (2015): “During cued learning the platform
protruded 2 cm above water surface and a “ﬂag” was attached
to it (visible escape platform). The maze was surrounded by
black curtains to minimize the availability of extra-maze cues.
For each of the four trials conducted on each day, the platform
was moved to a diﬀerent quadrant and a diﬀerent start location
was used. If a rat had not located the platform before 120 s
elapsed, it was gently guided to the platform location and was
allowed to remain there for 15 s. Inter-trial interval duration
was approximately 30 s. Two days of cued training were
conducted.”
Spatial learning and reference memory
Procedures employed were previously described by Galeano et al.
(2015): “Brieﬂy, the spatial learning task was conducted over
ﬁve consecutive days with four trials per day. During each trial,
a rat was gently released into the tank from one of the four
starting positions and it was able to escape from the water
using the hidden escape platform that was kept in the same
location throughout the ﬁve sessions of the spatial learning task.
A trial was ﬁnished when the rat found the escape platform
or when 120 s had elapsed, whichever occurred ﬁrst. If a rat
failed to ﬁnd the platform, the experimenter guided the animal
to it. Rats remained on the platform for 15 s. Inter-trial interval
duration was approximately 30 s. In each session, the four starting
positions were used and the order of the sequence was changed
pseudo-randomly between days. Twenty-four hours after the last
trial of the spatial learning task, reference memory was assessed
with a probe trial of 60 s in which the escape platform was
removed from the tank and each rat was released from a new
starting position not used during the spatial learning task. Time
spent in each quadrant was recorded. When sessions ﬁnished
rats were dried and returned to their home cage.” In addition,
platform crossings were also recorded as an additional measure
to assess animal performance during the probe trial.
Tissue Processing
At 30 days of age, rats were anesthetized with 28% (w/v) chloral
hydrate (0.1 ml/100 g of body weight). Next, animals were
intracardially perfused with 4% formaldehyde (freshly made
from paraformaldehyde; Sigma-Aldrich, St. Louis, MO, USA)
in 0.1 M phosphate buﬀer (pH 7.4). Subsequently, rats’ brains
were dissected and post-ﬁxed during 2 h in the formaldehyde
solution. Finally, rats’ brain were stored in 0.1 M PBS (pH 7.3)
containing 30% sucrose and 0.01% sodium azide (NaN3) at 4◦C
until further processing. Finally, 30-μm-thick coronal sections
were obtained using a freezing microtome and stored in PBS
with 0.002% (w/v) NaN3 at 4◦C until immunohistochemistry
procedures were carried out.
Immunohistochemistry
We assessed the immunohistochemical expression of NeuN,
glial ﬁbrillary acidic protein (GFAP), DAGLα, NAPE-PLD,
CB1, PPARα, and FAAH in the dorsal hippocampus. For this
purpose, 30 μm free ﬂoating sections were ﬁrst washed with
0.1 M PBS (pH 7.3), and then incubated in 50 mM citrate
buﬀer (pH 6) for 30 min at 80◦C. Next, sections were washed
three times in PBS (0.1 M, pH 7.3). In order to inactivate
the endogenous peroxidase, sections were then incubated in
3% H2O2 and 10% methanol in PBS (0.1 M) for 20 min
at room temperature. Following, sections were washed again
three times in PBS (0.1 M, pH 7.3) and blocked with 10%
donkey or goat serum diluted in PBS (containing 0.2% Triton
X-100). Next, free ﬂoating sections were incubated overnight
with the corresponding primary antibody at 4◦C [mouse anti-
NeuN (1:500, MAB377, Millipore); mouse anti-GFAP (1:500,
G3893, Sigma), rabbit anti-DAGLα (1:250, developed by our
group); guinea pig anti-NAPE-PLD (1:500, Frontier Institute);
rabbit anti-PPARα (1:100, P11120812, Fitzgerald); rabbit anti-
CB1 (1:200, Frontier Institute) and rabbit anti-FAAH (1:200,
157878, Cayman); Rivera et al., 2014a,b; procedures carried
out to develop polyclonal antibody against DAGLα were
described in detail by Suárez et al., 2008]. The next day,
sections were again washed three times in PBS (0.1 M, pH
7.3) and then incubated for 1 h at room temperature with
the corresponding biotinylated secondary antibody in a 1:500
dilution(goat anti-mouse IgG, 125K6063, Sigma; donkey anti-
rabbit IgG, 5356499, GEHealthcare; goat anti-guinea pig,W0726,
Vector Laboratories; Rivera et al., 2014a,b). Next, sections were
washed other three times in PBS (0.1 M, pH 7.3) and incubated
with the ExtrAvidin peroxidase complex (1:2000, Sigma,USA) for
1 h in the dark. Following three washes in PBS, immunolabeling
was revealed exposing sections to 0.05% diaminobenzidine
(Sigma, USA) and 0.03% H2O2 in PBS (in the case of CB1
and PPARα, nickel-DAB enhancement procedure was carried
out with the addition of 0.05% nickel ammonium sulfate). The
reaction was stopped using PBS and tissues were then washed
several times in PBS. To avoid variations in the intensity of
staining due to procedure, including potential diﬀerences in
the time that sections are exposed to DAB, batches (each one
Frontiers in Neuroanatomy | www.frontiersin.org 4 November 2015 | Volume 9 | Article 141
Blanco et al. Perinatal asphyxia and endocannabinoid system
containing approximately the same number of sections from
the three experimental groups) stained with the same primary
antibody were run simultaneously. In each batch, negative
controls were obtained by omitting primary antibody and no
background staining was observed for any of the secondary
antibodies employed (see Supplementary Material). Next, glass
slides, which were treated with poly-L-lysine solution (Sigma,
USA), were employed to mount the free ﬂoating sections.
Afterward, mounted sections were dehydrated in ascending
ethanol concentrations (50-70-96-100%), cleared with xylene and
coverslipped using Eukitt mounting medium (Kindler GmBH&
Co, Freiburg, Germany). Digital photomicrographs were taken
with a 10x objective (or 40x for insets) using the same conditions
of light and brightness/contrast employing an Olympus BX41
microscope coupled with an Olympus DP70 digital camera
(Olympus, Germany) or an Olympus BX60 microscope coupled
to Olympus DP71 digital camera (Olympus, USA). Total
magniﬁcation was 200x for those photomicrographs taken with
a 10x objective and 800x for those taken with a 40x objective
(insets).
Immunostaining Quantification
We examined 5–7 coronal sections obtained from Bregma levels:
-3.14 to -4.30 mm (dorsal hippocampus; Paxinos, 2007), in a
total of 5–6 animals per group. We focused on cornu ammonis
1 (CA1), cornu ammonis 3 (CA3), and dentate gyrus (DG).
In every section, immunoreactivity, or the number of positive
cells, was quantiﬁed in both hemispheres and averaged. From
each region and animal a mean was calculated and used for
subsequent statistical analysis. Percentage of reactive area (NeuN,
NAPE-PLD, and FAAH), densitometry (DAGLα, NAPE-PLD,
and CB1) and cell counting (GFAP and PPARα) were performed
using Image J 1.38X (NIH, USA). We used percentage of
reactive area in order to determine the tissue area that was
immunoreactive. Images were changed to binary code and the
positive staining was used to set the threshold, the optical
density was automatically determined and the percentage of
stained area was calculated over the total area of the frame
which was for all cases of 20060 μm2 (170 μm × 118 μm).
In order to measure levels of those markers that present diﬀuse
staining (DAGLα, CB1), we used densitometric quantiﬁcation
(Lopez-Rodriguez et al., 2014). Brieﬂy, each image was changed
to binary code, the area of interest was delineated by the
operator, and the optical density was automatically calculated.
For GFAP and PPARα, we determined the number of cells
per area using the “Cell Counter” Image J plugin tool. In
photomicrographs of sections stained with GFAP containing
CA1, CA3 or DG, we set 0.08 mm2 squares distributed so
that the whole section areas were represented. For PPARα,
we set 0.02 mm2 squares along the stratum pyramidale (sp)
of CA1 and CA3 and the granular cell layer (gcl) of DG, in
such a manner that the whole layers were totally represented.
Subsequently, we manually determined the number of cells
in each square and calculated the number of cells per mm2.
Each quantiﬁcation was made without knowledge of the
experimental groups coding the samples by an independent
experimenter.
Statistical Analysis
Results were shown as the mean ± SEM. Data were analyzed
by either one-way, two-way, or two-way mixed ANOVA tests
followed by Tukey’s post hoc tests for multiple comparisons (in
the case of behavioral data) or by Bonferroni’s correction
for multiple comparisons (for immunohistochemical
analysis), unless noted otherwise. When normality and/or
homoscedasticity were not met, non-parametric tests were
carried out (Kruskal–Wallis followed by Mann–Whitney tests).
A probability equal or less than 5% was considered signiﬁcant
(two-tailed). SSPS 15.0 for windows (SPSS, Inc., USA) were used
to perform statistical analyses.
RESULTS
Novel Object Recognition Test
One-way ANOVA tests carried out on d1 and d2 showed that the
main eﬀect of birth condition (CTL, C+, and PA) was signiﬁcant
in both cases [F(2,29) = 4.93, p < 0.05; F(2,29) = 4.15, p < 0.05,
respectively]. Post hoc multiple comparisons revealed that d1
and d2 scores were signiﬁcantly lower in the PA group than
in CTL and C+ groups (p < 0.05 for all the comparisons, see
Figures 1A,B). Moreover, one sample t-tests showed that d1
and d2 scores were signiﬁcantly diﬀerent from those expected
by chance in CTL and C+ groups (p < 0.01 for all cases; see
Figures 1A,B), but not in the PA group (p = n.s. for both scores;
see Figures 1A,B). These results indicated that PA rats explored
both objects, i.e., the novel and the familiar, a similar amount of
time during the choice trial, and thus it could be concluded that
recognition memory was impaired in this group of rats.
Morris Water Maze Test
Cued Learning
Two-way mixed ANOVA test indicated that the main eﬀect of
day was signiﬁcant [F(1,27) = 75.42, p < 0.001]. The main eﬀect
of birth condition and the interaction birth condition × day were
not (F < 1 in both cases). These results indicated that all groups
diminished their escape latency to reach the visible platform from
day 1 to 2 (see Figure 1C). This drop in escape latency was not
due to a decrease in swimming speed since none of the groups
showed a reduction in the latter from ﬁrst to second day (F< 1 for
the main eﬀects of day and birth condition and for the interaction
day × birth condition; see Figure 1D). A similar performance of
groups in the cued learning suggested that they did not have a
deﬁcit in their swimming abilities and were visually unimpaired.
Spatial Learning
To assess the performance of groups in the spatial learning phase
of the Morris water maze test, we carried out two-way mixed
ANOVA tests with birth condition as between-subject factor and
day as the within-subject factor. When the dependent variable
latency to platform was analyzed, results showed that the main
eﬀect of day was signiﬁcant [F(4,108) = 123.17, p < 0.001],
while the main eﬀect of birth condition and the interaction birth
condition × day were not [F(2,27) = 2.25, p= n.s.; F(8,108) = 1.54,
p = n.s., respectively]. Although the interaction did not reach
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FIGURE 1 | Behavioral assessment. (A) Discrimination indexes and (B) discrimination ratios of the CTL, C+ and PA groups in the choice trial of the NORT.
∗p < 0.05 vs. CTL; #p < 0.01 vs. C+; &&p < 0.01 vs. scores expected by chance (dashed lines). (C) Latencies to platform and (D) swimming speeds of the different
experimental groups during the cued learning phase of the MWM. †††p < 0.001 vs. day 1 for all the groups. (E) Latencies to platform and (F) swimming speeds of
the different experimental groups during the spatial learning phase of the MWM. ∗p < 0.05 vs. CTL; ∗∗p < 0.01 vs. CTL; #p < 0.05 vs. C+; ##p < 0.01 vs. C+.
(G) Percentages of time spent in the four quadrants and (H) number of platform crossings during the probe trial. ∗∗p < 0.01 vs. the percentage of time spent in the
target quadrant by the PA group (G) or vs. CTL (H); #p < 0.05 vs. the percentage of time spent in the target quadrant by the PA group (G) or vs. C+ (H); $p < 0.05
and $$p < 0.01 vs. the percentage of time spent in the target quadrant within the same group; &p < 0.05 and &&p < 0.01 vs. the percentage of time expected by
chance (25%; dashed line). CTL, control group; C+, cesarean section group; PA, perinatal asphyxia group; NORT, Novel Object Recognition Test; MWM, Morris
water maze test; L, left quadrant; T, target quadrant; R, right quadrant; O, opposite quadrant.
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signiﬁcance, Tukey’s post hoc tests for multiple comparisons
indicated that, on days 3 and 4, the PA group showed signiﬁcantly
higher latencies to reach the hidden platform than CTL and C+
groups (p< 0.05 or p< 0.01 for each comparison; see Figure 1E).
During the last day of the spatial learning phase, the PA group
displayed a higher latency to reach the hidden platform than the
CTL group (p < 0.05, see Figure 1E), but the latency was not
statistically diﬀerent from that showed by the C+ group (p= n.s.,
see Figure 1E). These results indicated that the PA group showed
a deﬁcit in the spatial learning phase of the watermaze. Regarding
swimming speed, the two-way mixed ANOVA test showed that
the main eﬀect of day was signiﬁcant [F(4,108) = 12.71, p< 0.001],
while the main eﬀect of birth condition and the interaction birth
condition × day were not (F < 1 for both cases). Furthermore,
any of the post hoc tests reached statistical signiﬁcance (see
Figure 1F). These results strongly suggested that the learning
deﬁcit showed by the PA group could not be better explained by
diﬀerences in swimming abilities and/or motivation to complete
the task.
Spatial Reference Memory
To analyze the percentage of time spent in each quadrant
during the probe trial, a two-way mixed ANOVA test, with birth
condition as between-subject factor and quadrant as within-
subject factor, was computed. Results showed that the main eﬀect
of quadrant and the interaction quadrant × birth condition
were signiﬁcant [F(3,81) = 9.89, p < 0.001; F(6,81) = 3.10,
p = 0.01, respectively], while the main eﬀect of birth condition
was not signiﬁcant (F < 1). Tukey’s post hoc tests for multiple
comparisons revealed that the CTL and C+ groups spent
signiﬁcantly greater percentages of time in the quadrant where
the platform was located during the spatial learning trials (target
quadrant) than in any of the other quadrants (p < 0.05 or
p < 0.01 for each comparison, see Figure 1G). On the contrary,
the PA group spent similar percentages of time in all quadrants
(p = n.s. for all the comparisons, see Figure 1G). In addition,
CTL and C+ groups spent signiﬁcantly greater percentages of
time in the target quadrant than the PA group (p < 0.01 and
p < 0.05, respectively; see Figure 1G). When we carried out
one sample t-tests to compare the percentages of time that
each group spent in each quadrant with the percentage of time
expected by chance (25%), results showed that CTL and C+
groups spent signiﬁcantly greater time in the target quadrant
than that expected by chance (t = 3.27, df = 9, p = 0.01;
t = 3.08, df = 9, p < 0.05, respectively), while the PA group
did not (t = −0.24, df = 9, p = n.s.). Finally, we analyzed the
number of times that rats crossed the area where the platform had
been located during the spatial learning trials, as an additional
indicator of the performances of animals in the probe trial.
Kruskal–Wallis test revealed that groups diﬀered in the number
of platform crossings (H = 9.84, p < 0.01). Post hoc Mann–
Whitney tests, with Bonferroni’s adjustment, showed that the
PA group crossed the former platform location signiﬁcantly less
times than CTL and C+ groups (U = 14, p < 0.01; U = 19.5,
p < 0.05, respectively; see Figure 1H). Overall, these results
indicated that the PA group did not exhibit a searching bias
toward the target quadrant and the former platform location,
and thus, this group presented a spatial reference memory
impairment.
NeuN and GFAP Immunostaining in
Dorsal Hippocampus
One-way ANOVA tests showed that the percentage of reactive
area for NeuN did not diﬀer between groups, either in CA1,
CA3, or DG regions of the dorsal hippocampus [CA1: F < 1;
CA3: F(2,15) = 1.87, p = n.s.; DG: F(2,15) = 1.24, p = n.s.; see
Figures 2A,B]. When analyzing the number of GFAP-positive
cells, we found that groups diﬀered between them in the studied
regions of the dorsal hippocampus [CA1: F(2,15) = 5.52, p< 0.05;
CA3: F(2,15) = 6.57, p < 0.01; DG: F(2,15) = 10.71, p < 0.01].
Post hoc multiple comparison tests revealed that the PA group
showed an increased number of GFAP-positive cells compared to
those measured in CTL and C+ groups in the three hippocampal
regions (p < 0.05 or p < 0.01 for all the comparisons; see
Figures 3A,B).
Immunohistochemical Expression of
DAGLα and NAPE-PLD in Dorsal
Hippocampus
One-way ANOVA tests showed that the mean optical densities of
DAGLα immunostaining were diﬀerent between groups in CA1
and DG regions [F(2,15) = 6.57, p< 0.01; F(2,15) = 6.60, p< 0.01,
respectively], while no statistically signiﬁcant diﬀerences were
observed in the CA3 region [F(2,15) = 1.61, p = n.s.]. Post hoc
pairwise comparison tests indicated that C+ and PA groups
showed signiﬁcantly higher mean optical densities than the CTL
group in the CA1 region (p < 0.05 for both cases; see Figure 4A,
upper panel, and 4B, left panel). In the DG region, the C+
group displayed a higher mean optical density than the CTL
group (p < 0.01; see Figure 4A, upper panel, and 4B, left panel),
while the mean optical density detected in the PA group was
not statistically diﬀerent than those detected in the CTL and C+
groups (p = n.s. for both comparisons; see Figure 4A, upper
panel, and 4B, left panel). Regarding the immunohistochemical
expression of NAPE-PLD, one-way ANOVA tests showed that the
percentages of reactive area were statistically diﬀerent between
groups in the studied hippocampal regions [CA1: F(2,15) = 10.16,
p < 0.01; CA3: F(2,15) = 6.58, p < 0.01; DG: F(2,15) = 5.45,
p < 0.05]. Post hoc multiple comparison tests revealed that PA
group showed a lower percentage of reactive area in CA1 and
CA3 regions than the ones measured in CTL and C+ groups
(p< 0.05 or p< 0.01 for all the comparisons; see Figure 4A lower
panel and 4B, right panel). In the DG, the PA group showed a
lower percentage of reactive area than that measured in the C+
group (p< 0.05; see Figure 4A, lower panel and 4B, right panel),
but no statistically signiﬁcant diﬀerences were found between PA
and CTL groups (p = n.s.; see Figure 4A, lower panel and 4B,
right panel).
Immunohistochemical Expression of
CB1 and PPARα in Dorsal Hippocampus
The analysis of the immunohistochemical expression of CB1
in dorsal hippocampus revealed that there are no signiﬁcant
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FIGURE 2 | NeuN immunostaining in dorsal hippocampus. (A) Photomicrographs of NeuN-positive cells in CA1, CA3, and DG regions of the dorsal
hippocampus in CTL, C+ and PA groups. Scale bars = 15 μm. (B) Percentage of NeuN immunopositive area in CA1, CA3, and DG regions of the dorsal
hippocampus in all the experimental groups. Bars and error bars show the mean + SEM of 5–7 observations per animal of a total of six rats per group. CTL, control
group; C+, cesarean section group; PA, perinatal asphyxia group; CA1, cornu ammonis 1; CA3, cornu ammonis 3; DG, dentate gyrus.
diﬀerences between groups in none of the quantiﬁed regions
(F < 1 for CA1, CA3, and DG; see Figure 5A, upper panel,
and 5B, left panel). The number of PPAR-positive cells diﬀered
between groups in the CA1 and CA3 regions [F(2,15) = 7.94,
p < 0.01; F(2,15) = 11.38, p < 0.01, respectively], while no
diﬀerences were observed in the DG [F(2,15) = 1.92, p= n.s.]. Post
hoc pairwise comparison tests showed that, in the PA group, the
number of PPAR-positive cells was signiﬁcantly lower compared
to those measured in CTL and C+ groups (p < 0.05 or p < 0.01
for all the comparisons; see Figure 5A, lower panel, and 5B, right
panel).
Immunohistochemical Expression of
FAAH in Dorsal Hippocampus
The percentages of reactive area only diﬀered between groups in
the CA3 region [CA1: F < 1; CA3: F(2,15) = 12.13, p < 0.001;
DG: F < 1]. Post hoc multiple comparison tests indicated
that the C+ group showed a signiﬁcantly higher percentage of
reactive area than that observed in the CTL and PA groups
in the CA3 region (p < 0.001 and p < 0.05, respectively; see
Figures 6A,B).
DISCUSSION
In last years, the ECS has received growing attention as new
evidences show it plays a fundamental role in a myriad of brain
processes, including synaptic plasticity, neurogenesis, learning
and memory, mood regulation, reward processes, central control
of feeding behavior, among others (Bermudez-Silva et al., 2010;
Cachope, 2012; Mechoulam and Parker, 2013). Moreover, the
modulation of the ECS seems to exert neuroprotective actions in
several models of neonatal hypoxia-ischemia and adult cerebral
ischemia (Degn et al., 2007; Alonso-Alconada et al., 2011;
Fernández-López et al., 2013; Esposito et al., 2014; England
et al., 2015). For instance, endocannabinoids (AEA and 2-AG)
were demostrated to reduce brain injury in preweaning or adult
rats that were submitted to a hypoxic-ischemic episode or an
excitotoxic brain lesion during the neonatal period (Shouman
et al., 2006; Carloni et al., 2012; Lara-Celador et al., 2012).
The CB1/CB2 receptor agonist, WIN-55212, has also showed
to exert neuroprotective actions in neonatal hypoxia-ischemia,
preventing early and delayed neuronal death (Martínez-Orgado
et al., 2003). The prevention of delayed neuronal death was
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FIGURE 3 | Glial fibrillary acidic protein (GFAP) immunostaining in dorsal hippocampus. (A) Representative photomicrographs showing GFAP-positive cells
in CA1, CA3, and DG regions of the dorsal hippocampus in the different experimental groups. Scale bars = 15 and 3 μm in insets. (B) Quantification of the number
of GFAP-positive cells in CA1, CA3, and DG regions of the dorsal hippocampus in the different experimental groups. Bars and error bars show the mean + SEM of
5–7 observations per animal of a total of six rats per group. ∗p < 0.05 vs. CTL; ∗∗p < 0.01 vs. CTL; #p < 0.05 vs. C+; ##p < 0.01 vs. C+. CTL, control group; C+,
cesarean section group; PA, perinatal asphyxia group; CA1, cornu ammonis 1; CA3, cornu ammonis 3; DG, dentate gyrus.
mediated through CB1-dependent mechanisms, because the
co-administration of the cannabinoid CB1 receptor antagonist
SR141716 abolished the WIN-55212-induced prevention eﬀect
(Martínez-Orgado et al., 2003). In the case of AEs devoid of
cannabinoid activity, Zhou et al. (2012) have demonstrated
that the administration of OEA previous to the induction of
ischemic brain injury reduced infarct volume and alleviated
brain edema in adult mice. This neuroprotective eﬀect was
mediated by the increased expression of PPARα induced by
the OEA administration (Zhou et al., 2012). Interestingly, in
the present study we found a reduced expression of NAPE-
PLD, an enzyme that mediates OEA synthesis, along with a
reduction of the expression of OEA receptor PPARα, suggesting
that the potential neuroprotective role of this system is
impaired.
Asphyctic Rats Show Cognitive
Impairments Associated with
Astrogliosis in the Hippocampus in the
Absence of Neuronal Loss
At a behavioral level, the results of this study indicate that PA
is associated with impairments in recognition memory, spatial
learning, and reference memory in the Morris water maze
(Figures 1A–H). In previous works, we demonstrated that 3-
and 18-months-old rats that were submitted to PA also display
spatial learning and reference memory deﬁcits in the Morris
water maze (Galeano et al., 2011, 2015). With the addition of
these results, we can conclude that spatial and reference memory
impairments are presented as early as 30 days after PA and
prevail, at least, until middle age. In relation to recognition
memory, we were not previously able to detect an impairment in
this kind of memory in 18-months-old asphyctic rats (Galeano
et al., 2015). As it was discussed in the cited study, 1 h of
inter-trial interval between sample and choice trials could be
too short to reveal group diﬀerences. In this study, we extended
the inter-trial interval to 4 h and we were able to detect a
recognition memory impairment in the PA group. Another
important diﬀerence, between the present and the previous
study, is the age of the animals. Young adult asphyctic rats
(1-month-old) were employed in the present study while middle-
aged asphyctic rats (18-months-old) were used in the previous
one. Middle-aged control rats might have subtle deﬁcits in
recognition memory that could make more diﬃcult to reveal
statistically signiﬁcant diﬀerences when compared with asphyctic
group.
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FIGURE 4 | Immunohistochemical expression of DAGLα and NAPE-PLD in dorsal hippocampus. (A) Photomicrographs showing DAGLα (upper panel) and
NAPE-PLD (lower panel) immunostaining in CA1, CA3, and DG regions of the dorsal hippocampus in the different experimental groups. Scale bars = 17 μm.
(B) Immunostaining quantification of DAGLα (left panel) and NAPE-PLD (right panel) in CA1, CA3, and DG regions of the dorsal hippocampus in all groups. DAGLα
immureactivity was measured by densitometry while NAPE-PLD positive immunostaining was quantified as the percentage of the stained area over the total area of
the region of interest. Bars and error bars show the mean + SEM of 5–7 observations per animal of a total of six rats per group. ∗p < 0.05 vs. CTL; ∗∗p < 0.01 vs.
CTL; #p < 0.05 vs. C+; ##p < 0.01 vs. C+. CTL, control group; C+, cesarean section group; PA, perinatal asphyxia group; CA1, cornu ammonis 1; CA3, cornu
ammonis 3; DG, dentate gyrus.
These cognitive deﬁcits were somehow expected because both
behavioral tests are hippocampal-dependent tasks (Clark et al.,
2000; Vorhees and Williams, 2014), and the hippocampus is one
of the most aﬀected structures by PA, both in animal models
and humans (Vannucci, 1990; Kasdorf et al., 2014). In fact, we
observed a strong astroglial reaction in the hippocampus of
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FIGURE 5 | Immunohistochemical expression of CB1 and PPARα in dorsal hippocampus. (A) Photomicrographs of CB1 (upper panel) and PPARα (lower
panel) immunostaining in CA1, CA3, and DG regions of the dorsal hippocampus in CTL, C+, and PA groups. Scale bars = 15 μm. (B) Densitometric quantification
of CB1 (left panel) and number of PPARα positive nuclei per mm2 (right panel) in the Stratum pyramidale of the CA1 and CA3 areas, and in the granular cell layer of
the DG region, in the different experimental groups. Bars and error bars show the mean + SEM of 5–7 observations per experimental subject of a total of 5–6
animals per group. ∗p < 0.05 vs. CTL; ∗∗p < 0.01 vs. CTL; ##p < 0.01 vs. C+. CTL, control group; C+, cesarean section group; PA, perinatal asphyxia group; CA1,
cornu ammonis 1; CA3, cornu ammonis 3; DG, dentate gyrus.
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FIGURE 6 | Immunohistochemical expression of FAAH in dorsal hippocampus. (A) Representative photomicrographs showing positive immunostaining of
FAAH in CA1, CA3, and DG regions of the dorsal hippocampus in the different groups (CTL, C+, and PA). Scale bars = 15 and 3 μm in insets. (B) Quantification of
FAAH, as the percentage of stained area over the total area of the region of interest, in CA1, CA3, and DG regions of the dorsal hippocampus in the different
experimental groups. Bars and error bars show the mean + SEM of 5–7 observations per rat of a total of six animals per group. ∗∗∗p < 0.001 vs. CTL; &p < 0.05 vs.
PA. CTL, control group; C+, cesarean section group; PA, perinatal asphyxia group; CA1, cornu ammonis 1; CA3, cornu ammonis 3; DG, dentate gyrus.
asphyctic animals (see Figures 2A,B, left panel). This astroglial
reaction was not accompanied by neuronal loss as it was
previously reported by our group in this model of PA (Saraceno
et al., 2010, 2012).
Perinatal Asphyxia is Associated with a
Reduced Expression of NAPE-PLD and
PPARα
When we studied the expression of enzymes responsible for
synthesis (DAGLα and NAPE-PLD) and degradation (FAAH)
of endocannabinoids and receptors related to endocannabinoids
(CB1 and PPARα), we observed a strong decrease in the
expression of NAPE-PLD and PPARα in the dorsal hippocampus
(Figure 4A, lower panel; 4B, right panel; 5A, lower panel
and 5B, right panel). This reduced expression could not be
better explained by the cesarean section because it was speciﬁc
for the asphyctic group. NAPE-PLD is the primary enzyme
that catalyzes the release of AEs and consequently the basal
levels of endocannabinoid AEA and other non-cannabinoid
congeners, such as OEA and PEA, could be aﬀected in the
cerebral areas studied. In relation to PPARα, this receptor
has been reported to mediate the neuroprotective eﬀect of
non-cannabinoid AEs in cognitive impairment, inﬂammation,
neurodegeneration and neuronal damage after ischemia (Ahmad
et al., 2012; Zhou et al., 2012; Yang et al., 2015). Taken together,
the reduction of both NAPE-PLD and PPARα may indicate that
AEs with no cannabinoid activity are aﬀected in hippocampus of
asphyctic animals. This ﬁnding is relevant because OEA and PEA
have shown neuroprotective eﬀects in adult cerebral ischemia
(Ahmad et al., 2012; Zhou et al., 2012). Interestingly, we have
recently reported a co-expression of NAPE-PLD and PPARα in
hippocampal subpopulations of neurons in the rat and this may
implicate a coordinated regulation of the biological roles of the
PPARα signaling system through the release of OEA/PEA (Rivera
et al., 2014b). Moreover, the decrease in PPARα and NAPE-
PLD levels may be linked to the increment in the number of
astrocytes since it has been previously shown that cannabinoids
as well as PEA, and its nuclear receptor PPARα, are implicated
in the inhibition of astrocytic activation in the hippocampus
(Xu et al., 2006; Esposito et al., 2007; Scuderi et al., 2011,
2012). This decrease in PPARα is in accordance with previous
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results in which hypoxia inducible factor 1-alpha (HIF-1α) has
been proven to interact with PPARα during a hypoxic event
down regulating the expression of the latter (Narravula and
Colgan, 2001). Moreover, the decrease in NAPE-PLD levels is
also consistent with previous data that have shown a reduced
activity of the enzyme after cerebral ischemia despite presenting
no changes in mRNA quantities after the ischemic insult (Degn
et al., 2007). According to our results this decrease in NAPE-
PLD activity could be due to changes in post-transcriptional
regulation of the protein resulting in diminished levels of said
enzyme in hippocampus. Due to the fact that NAPE-PLD is
necessary to synthesize AEs, such as the endocannabinoid AEA,
changes in this enzyme levels could lead to modiﬁcations in
diﬀerent components of the ECS. In relation to this it is important
to mention that we did not observe changes in CB1 receptor
levels (Figure 5A, upper panel, 5B, left panel). Therefore,
further studies are needed to determine the mechanisms by
which hypoxia dysregulates the ECS/AEs signaling system in the
hippocampus.
Fatty acid amide hydrolase was found to be signiﬁcantly
increased in the C+ group in comparison with CTL and PA
groups (Figures 6A,B). But in contrast to NAPE-PLD and
PPARα, the increment of FAAHwas restricted to the CA3 area of
the hippocampus. This precludes us to draw a conclusion about
their potential role in cesarean delivery.
Reduced Expression of NAPE-PLD and
PPARα May be Involved in PA-induced
Hippocampal Neurogenesis
It is well-known that after a perinatal or adult hypoxia-ischemia
episode an increment of hippocampal neurogenesis takes place
(Türeyen et al., 2002; Morales et al., 2008). Although mechanisms
underlying this neurogenic response are poorly understood, it is
believed that its function is to try to repair the damage produced
by the reduction of oxygen supply and/or reoxygenation. In the
model of perinatal hypoxia-ischemia employed in the present
study, hippocampal neurogenesis reaches its peak 1 week after
PA which coincides with the seventh postnatal day since PA is
produced at delivery (Morales et al., 2008). At the 30th postnatal
day, cell proliferation is still increased (Morales et al., 2008). Since
asphyctic rats showed memory impairments 1 month after PA, it
could be concluded that the enhanced hippocampal neurogenesis
did not translate into functional recovery. Another possibility
is that this increased neurogenic response could be an aberrant
phenomenon that may be responsible, in part, of the memory
dysfunction (Shetty, 2014). Speciﬁc experiments are needed to
know which of these two scenarios are more likely to underlie
memory impairment after PA. On the other hand, ECS/AEs are
involved in the control of neurogenesis (Rivera et al., 2015).
Therefore, it is possible that some of the alterations found in the
ECS/AEs in the present study could mediate the increment of
hippocampal neurogenesis reported in this model of PA. Rivera
et al. (2015) recently reported that pharmacological inhibition
of FAAH, which was accompanied by increased plasma levels of
OEA, PEA and AEA, was associated to a reduction of neurogenic
cell proliferation in the hippocampus. The reduced hippocampal
levels of NAPE-PLD and PPARα observed in the present study
suggest reduced levels of AEs, such as OEA and PEA, and reduced
AEA activity (by the so-called “entourage eﬀect”), and thus could
be one of the mechanisms that underlies increase hippocampal
neurogenic response after PA.
CONCLUSION
The most remarkable ﬁndings of the present study are that PA
is associated with: (i) First, a potent reduction of the expression
of the enzyme responsible of the synthesis of AEs (NAPE-PLD)
in CA1 and CA3 hippocampal areas; (ii) Second, a reduction of
the expression of the nuclear receptor PPARα, which mediates
the action of AEs with no endocannabinoid activity, in both
hippocampal areas CA1 and CA3. In addition, asphyctic rats
showed impaired recognition and spatial reference memory that
were accompanied by hippocampal astrogliosis without neuronal
loss. Overall, these results may indicate a dysregulation of non-
cannabinoid AEs in the hippocampus of postweaned asphyctic
rats and encourage conducting future studies using AEs as
potential neuroprotective compounds in animal models of PA.
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